Your browser doesn't support javascript.
loading
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.
Kirk, Allan D; Mannon, Roslyn B; Kleiner, David E; Swanson, John S; Kampen, Robert L; Cendales, Linda K; Elster, Eric A; Wakefield, Terri; Chamberlain, Christine; Hoffmann, Steven C; Hale, Douglas A.
Affiliation
  • Kirk AD; Transplantation Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Transplantation ; 80(8): 1051-9, 2005 Oct 27.
Article in En | MEDLINE | ID: mdl-16278585
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Depletion / Kidney Transplantation / Transplantation Tolerance / Guanidines / Immunosuppressive Agents / Antibodies, Monoclonal / Antibodies, Neoplasm Type of study: Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Depletion / Kidney Transplantation / Transplantation Tolerance / Guanidines / Immunosuppressive Agents / Antibodies, Monoclonal / Antibodies, Neoplasm Type of study: Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States